Tianjun Guan

878 total citations
33 papers, 367 citations indexed

About

Tianjun Guan is a scholar working on Nephrology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Tianjun Guan has authored 33 papers receiving a total of 367 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Nephrology, 9 papers in Pulmonary and Respiratory Medicine and 8 papers in Molecular Biology. Recurrent topics in Tianjun Guan's work include Renal Diseases and Glomerulopathies (9 papers), Chronic Kidney Disease and Diabetes (7 papers) and Dialysis and Renal Disease Management (4 papers). Tianjun Guan is often cited by papers focused on Renal Diseases and Glomerulopathies (9 papers), Chronic Kidney Disease and Diabetes (7 papers) and Dialysis and Renal Disease Management (4 papers). Tianjun Guan collaborates with scholars based in China and United States. Tianjun Guan's co-authors include Anqun Chen, John Cijiang He, Kyung Lee, Bo Xu, Detlef Schlöndorff, Chengguo Wei, Jia Fu, Qing Gao, Vivette D. D’Agati and Lan Chen and has published in prestigious journals such as Journal of Clinical Investigation, SHILAP Revista de lepidopterología and Bioconjugate Chemistry.

In The Last Decade

Tianjun Guan

30 papers receiving 360 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Tianjun Guan China	10	171	87	78	65	58	33	367
Kinga Musiał Poland	13	208 1.2×	117 1.3×	64 0.8×	35 0.5×	53 0.9×	59	488
Zhuxing Sun China	11	208 1.2×	71 0.8×	26 0.3×	45 0.7×	78 1.3×	26	341
Kres̆imir Gales̃ić Croatia	12	209 1.2×	47 0.5×	43 0.6×	49 0.8×	179 3.1×	61	474
James M. Chevalier United States	9	156 0.9×	49 0.6×	43 0.6×	19 0.3×	43 0.7×	17	331
Yan Li-jun China	7	142 0.8×	88 1.0×	53 0.7×	39 0.6×	27 0.5×	12	347
Janka Franeková Czechia	15	102 0.6×	113 1.3×	64 0.8×	48 0.7×	37 0.6×	58	557
Hanlu Ding China	7	188 1.1×	41 0.5×	113 1.4×	33 0.5×	47 0.8×	17	388
Emiko Fujita Japan	13	204 1.2×	95 1.1×	99 1.3×	36 0.6×	69 1.2×	18	418
Panagiotis Pateinakis Greece	10	208 1.2×	57 0.7×	61 0.8×	35 0.5×	52 0.9×	32	410

Countries citing papers authored by Tianjun Guan

Since Specialization

Citations

This map shows the geographic impact of Tianjun Guan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tianjun Guan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tianjun Guan more than expected).

Fields of papers citing papers by Tianjun Guan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tianjun Guan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tianjun Guan. The network helps show where Tianjun Guan may publish in the future.

Co-authorship network of co-authors of Tianjun Guan

This figure shows the co-authorship network connecting the top 25 collaborators of Tianjun Guan. A scholar is included among the top collaborators of Tianjun Guan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tianjun Guan. Tianjun Guan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Li, Yu, et al.. (2025). Efficacy and safety of finerenone in non-diabetic CKD patients: a single-center, real-world, retrospective study. BMC Nephrology. 26(1). 323–323.

Pan, Mingming, Min Gao, Yan Xu, et al.. (2025). Efficacy and safety of HSK21542 for pruritus management in hemodialysis patients: a multicenter, randomized, double-blind, placebo-controlled trial. Frontiers in Pharmacology. 16. 1583515–1583515.

Chen, Huiting, et al.. (2024). Ferroptosis-related genes, a novel therapeutic target for focal segmental glomerulosclerosis. BMC Nephrology. 25(1). 58–58. 3 indexed citations

Pan, Mingming, Li Zhou, Yan Xu, et al.. (2023). Safety and effectiveness of HSK21542 for hemodialysis patients: a multiple ascending dose study. Frontiers in Pharmacology. 14. 1203642–1203642. 5 indexed citations

Tian, Yuchen, et al.. (2023). Common Key Genes in Differentiating Parathyroid Adenoma From Thyroid Adenoma. Hormone and Metabolic Research. 55(3). 212–221. 1 indexed citations

Li, Yu, et al.. (2023). Clinicopathologic features and long-term prognosis of hepatitis B virus-associated glomerulonephritis: a retrospective cohort study. Journal of Nephrology. 36(8). 2335–2344. 1 indexed citations

Gan, Liangying, Lei Xing, Linghui Zhou, et al.. (2023). Tenapanor in Chinese ESRD patients with hyperphosphatemia on haemodialysis: a randomised, phase 3 trial. Clinical Kidney Journal. 17(1). 3 indexed citations

Xiao, Liangxiang, Anqun Chen, Qing Gao, et al.. (2022). Pentosan polysulfate ameliorates fibrosis and inflammation markers in SV40 MES13 cells by suppressing activation of PI3K/AKT pathway via miR-446a-3p. BMC Nephrology. 23(1). 105–105. 6 indexed citations

Guan, Tianjun, et al.. (2022). Acute Kidney Injury in Adult Patients With Hepatocellular Carcinoma After TACE or Hepatectomy Treatment. Frontiers in Oncology. 12. 627895–627895. 5 indexed citations

10.

Guan, Tianjun, et al.. (2021). Acute Kidney Injury During Extracorporeal Membrane Oxygenation: VA ECMO Versus VV ECMO. Journal of Intensive Care Medicine. 37(6). 743–752. 11 indexed citations

11.

Zong, Rongrong, Wei Han, Guo‐Liang Wang, et al.. (2021). Tear dynamics testing and quantitative proteomics analysis in patients with chronic renal failure. Journal of Proteomics. 248. 104351–104351. 12 indexed citations

12.

Tian, Yuchen, et al.. (2021). Polymeric RNAi Constructs Tailored with Appreciable Transcellular Trafficking Functions for Potential Suppression of Parathyroid Hormone Production. Bioconjugate Chemistry. 32(5). 909–915.

13.

Hong, Xue, et al.. (2021). Exogenous Wnt1 Prevents Acute Kidney Injury and Its Subsequent Progression to Chronic Kidney Disease. Frontiers in Physiology. 12. 745816–745816. 5 indexed citations

14.

Zhuang, Yongze, et al.. (2020). Severity of Intrarenal Arterial Lesions Can Predict the Clinical Prognosis of Hepatitis B Virus-Associated Glomerulonephritis: A Retrospective Study. SHILAP Revista de lepidopterología. 7(1). 67–78. 2 indexed citations

15.

Chen, Anqun, Feng Ye, Han Lai, et al.. (2020). Soluble RARRES1 induces podocyte apoptosis to promote glomerular disease progression. Journal of Clinical Investigation. 130(10). 5523–5535. 65 indexed citations

16.

Guan, Tianjun, et al.. (2020). Silencing PEG3 inhibits renal fibrosis in a rat model of diabetic nephropathy by suppressing the NF-κB pathway. Molecular and Cellular Endocrinology. 513. 110823–110823. 5 indexed citations

17.

Zhang, Minfang, Chaojun Qi, Yan Zha, et al.. (2018). Leflunomide versus cyclophosphamide in the induction treatment of proliferative lupus nephritis in Chinese patients: a randomized trial. Clinical Rheumatology. 38(3). 859–867. 31 indexed citations

18.

Chen, Lan, et al.. (2015). High Dose ESAs Are Associated with High iPTH Levels in Hemodialysis Patients with End-Stage Kidney Disease: A Retrospective Analysis. Frontiers in Public Health. 3. 258–258. 9 indexed citations

19.

Guan, Tianjun, et al.. (2014). Effects of polycystin-1 N-terminal fragment fusion protein on the proliferation and apoptosis of rat mesangial cells. Molecular Medicine Reports. 10(3). 1626–1634. 1 indexed citations

20.

Chen, Lan, et al.. (2013). Combined use of heparin and anisodamine reduces the risk of early thrombosis in native arteriovenous fistula. Vascular. 21(6). 369–374. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact